AU2003274551A1 - Quinoline derivatives - Google Patents

Quinoline derivatives

Info

Publication number
AU2003274551A1
AU2003274551A1 AU2003274551A AU2003274551A AU2003274551A1 AU 2003274551 A1 AU2003274551 A1 AU 2003274551A1 AU 2003274551 A AU2003274551 A AU 2003274551A AU 2003274551 A AU2003274551 A AU 2003274551A AU 2003274551 A1 AU2003274551 A1 AU 2003274551A1
Authority
AU
Australia
Prior art keywords
quinoline derivatives
quinoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003274551A
Inventor
Gene Michael Bright
Bishop Wlodecki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of AU2003274551A1 publication Critical patent/AU2003274551A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003274551A 2002-11-12 2003-10-31 Quinoline derivatives Abandoned AU2003274551A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42551802P 2002-11-12 2002-11-12
US60/425,518 2002-11-12
PCT/IB2003/004903 WO2004043929A1 (en) 2002-11-12 2003-10-31 Quinoline derivatives

Publications (1)

Publication Number Publication Date
AU2003274551A1 true AU2003274551A1 (en) 2004-06-03

Family

ID=32313003

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003274551A Abandoned AU2003274551A1 (en) 2002-11-12 2003-10-31 Quinoline derivatives

Country Status (7)

Country Link
EP (1) EP1562908A1 (en)
JP (1) JP2006508113A (en)
AU (1) AU2003274551A1 (en)
BR (1) BR0316164A (en)
CA (1) CA2505873A1 (en)
MX (1) MXPA05005111A (en)
WO (1) WO2004043929A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201209587D0 (en) 2012-05-30 2012-07-11 Takeda Pharmaceutical Therapeutic compounds
GB201320905D0 (en) * 2013-11-27 2014-01-08 Takeda Pharmaceutical Therapeutic compounds
US10865185B2 (en) 2015-08-21 2020-12-15 Srx Cardio, Llc Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity
EP3337788A4 (en) 2015-08-21 2019-03-27 Portola Pharmaceuticals, Inc. Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (pcsk9) modulators and their use
US10821106B2 (en) 2015-08-21 2020-11-03 Srx Cardio, Llc Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity
EP3390389B1 (en) 2015-12-17 2021-05-19 Merck Patent GmbH Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
WO2017147328A1 (en) 2016-02-23 2017-08-31 Portola Pharmaceuticals, Inc. Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
ES2805030T3 (en) * 2016-07-14 2021-02-10 Bristol Myers Squibb Co Heteroaryl substituted monocyclic compounds
US10947214B2 (en) 2016-08-08 2021-03-16 Merck Patent Gmbh TLR7/8 antagonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE812911C (en) * 1945-03-12 1951-09-06 Rhone Poulenc Sa Process for the preparation of new substituted derivatives of piperidine
FR2560873B1 (en) * 1984-03-09 1986-09-26 Rhone Poulenc Sante DRUGS BASED ON PIPERIDINE DERIVATIVES, NOVEL PIPERIDINE DERIVATIVES AND THEIR PREPARATION METHODS

Also Published As

Publication number Publication date
BR0316164A (en) 2005-09-27
MXPA05005111A (en) 2005-07-01
WO2004043929A1 (en) 2004-05-27
EP1562908A1 (en) 2005-08-17
CA2505873A1 (en) 2004-05-27
JP2006508113A (en) 2006-03-09

Similar Documents

Publication Publication Date Title
HRP20041031A2 (en) Quinolinone derivatives
EP1682493B8 (en) Amidoacetonitrile derivatives
AU2003245700A1 (en) Pyrazolopyridine derivatives
AU2003211362A1 (en) N-hydroxycarboxamide derivative
AU2003255492A1 (en) Heterocyclic derivatives
EP1606277B8 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
AU2003273064A1 (en) Quinoline-3-carboxamide compound
AU2003227712A1 (en) Tetrahydroisoquinoline derivatives
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
PL376997A1 (en) Tetrahydroquinoline derivatives
AU2002347336A1 (en) Quinoline derivatives
AU2003264753A1 (en) 1-sulphonyl piperidine derivatives
PL377318A1 (en) Tetrahydroquinoline derivatives
AU2003303648A1 (en) Novel 5-hydroxyindole-3-carboxylate derivatives
AU2002347359A1 (en) Quinoline derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003278369A1 (en) 3-cyano-quinoline derivatives
EP1706373B8 (en) Amidoacetonitrile derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
HK1071364A1 (en) Quinoline derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003274551A1 (en) Quinoline derivatives
AU2003289222A1 (en) Benzomorpholine derivatives
AU2003252333A1 (en) Novel tetrahydroquinoline derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase